The University of Southampton
University of Southampton Institutional Repository

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the available evidence and are presented as recommendations to aid clinical decision making in primary and secondary medical care. They may also serve as a source of information for patients and their carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting involving experts in anxiety disorders reviewed the main subject areas and considered the strength of evidence and its clinical implications. The guidelines were constructed after extensive feedback from participants and interested parties. The strength of supporting evidence for recommendations was rated. The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments.
anticonvulsants • antidepressants • antipsychotics • anxiety disorders • anxiolytics • benzodiazepines • cognitive behaviour therapy • evidence-based guidelines • generalized anxiety disorder • obsessive-compulsive disorder • panic disorder • post-traumatic stress disorder • simple phobia • social phobia • SSRI • treatment • venlafaxine
0269-8811
567-596
Baldwin, David S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Anderson, Ian M.
6d3a0737-2a8e-49a3-bed2-0dc5bbacfc86
Nutt, David J.
d0ea03e2-172d-4888-bfd0-239dc7c953cb
Bandelow, Borwin
2fbbae21-629e-4d76-b5d0-7dff1282d64d
Bond, A.
c939c3a0-43a3-42de-986d-fb09353bb1ce
Davidson, Jonathan R.T.
1c4d8510-4b2b-4775-b5a2-b9a08b9556ac
den Boer, J.A.
59d684e4-3d37-4df6-965c-e030b7f0ab2f
Fineberg, Naomi A.
157dcac1-9fb2-4197-81f3-0167e1224f05
Knapp, Martin
39b0d60c-30b1-4b9b-bc7f-13c5bdc7e712
Scott, J.
d66f6ef2-64d7-4c3c-966b-bcc61eddf20c
Wittchen, H.-U.
6a28d6e8-5631-4277-9d5e-b16089e2b3b2
Baldwin, David S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Anderson, Ian M.
6d3a0737-2a8e-49a3-bed2-0dc5bbacfc86
Nutt, David J.
d0ea03e2-172d-4888-bfd0-239dc7c953cb
Bandelow, Borwin
2fbbae21-629e-4d76-b5d0-7dff1282d64d
Bond, A.
c939c3a0-43a3-42de-986d-fb09353bb1ce
Davidson, Jonathan R.T.
1c4d8510-4b2b-4775-b5a2-b9a08b9556ac
den Boer, J.A.
59d684e4-3d37-4df6-965c-e030b7f0ab2f
Fineberg, Naomi A.
157dcac1-9fb2-4197-81f3-0167e1224f05
Knapp, Martin
39b0d60c-30b1-4b9b-bc7f-13c5bdc7e712
Scott, J.
d66f6ef2-64d7-4c3c-966b-bcc61eddf20c
Wittchen, H.-U.
6a28d6e8-5631-4277-9d5e-b16089e2b3b2

Baldwin, David S., Anderson, Ian M., Nutt, David J., Bandelow, Borwin, Bond, A., Davidson, Jonathan R.T., den Boer, J.A., Fineberg, Naomi A., Knapp, Martin, Scott, J. and Wittchen, H.-U. (2005) Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 19 (6), 567-596. (doi:10.1177/0269881105059253).

Record type: Article

Abstract

These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the available evidence and are presented as recommendations to aid clinical decision making in primary and secondary medical care. They may also serve as a source of information for patients and their carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting involving experts in anxiety disorders reviewed the main subject areas and considered the strength of evidence and its clinical implications. The guidelines were constructed after extensive feedback from participants and interested parties. The strength of supporting evidence for recommendations was rated. The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments.

Full text not available from this repository.

More information

Published date: June 2005
Keywords: anticonvulsants • antidepressants • antipsychotics • anxiety disorders • anxiolytics • benzodiazepines • cognitive behaviour therapy • evidence-based guidelines • generalized anxiety disorder • obsessive-compulsive disorder • panic disorder • post-traumatic stress disorder • simple phobia • social phobia • SSRI • treatment • venlafaxine

Identifiers

Local EPrints ID: 62250
URI: http://eprints.soton.ac.uk/id/eprint/62250
ISSN: 0269-8811
PURE UUID: ba804893-f03a-4876-9977-3713e79dcdb6

Catalogue record

Date deposited: 12 Sep 2008
Last modified: 13 Mar 2019 20:27

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×